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their eyes enucleated and processed for immunohistochemical detection
of ETA, synaptic protein PSD95 or c-fos. Also seriate retina cryosections
were stainedwith neutral red, and thickness of outer nuclear layer (ONL)
was measured to determine the level of light-induced damage. After 4
days of phototoxic exposure, damage to the retina was higher in the
temporal than in the nasal retina, and the largest attrition occurred
around the optic nerve head. The retina of mice receiving Clazosentan
during light exposure showed less damage than those receiving saline.
After 2 days of phototoxic exposure, ETA-IR in the outer plexiform layer
(OPL) was lower in animals treated with clazosentan than in saline
controls. PSD95-IR, by contrast, was higher in clazosentan-treated mice
than in the corresponding controls. After low light stimulation more c-
fos + nuclei appeared in the INL and the GCL of clazosentan-treatedmice
than in the controls. Treatmentwith clazosentan decreased light-induced
damage. Our experiments indicated that this phenomenon could be
associated with changes in synaptic terminals of the OPL. The larger
number of c-fos + nuclei in light-stimulated retinas suggests that
transmission in the OPL would be facilitated by inhibition of ETA
receptors. Taking all into account we postulate that ETA receptors might
modulate photoreceptor transmission between the outer and the inner
retina. Furthermore, these phenomena could be involved an increased
protection of photoreceptors to light-induced damage.
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Cerebral malaria (CM) is a life-threatening complication of
Plasmodium falciparum. Infection of C57BL/6 (B6) mice with Plasmo-
dium berghei ANKA (PbA) is an experimental CM (ECM) model which
recapitulates many aspects of CM. Infection of B6 mice with
P. berghei NK65 (PbN) does not induce neurological complications,
and this is used as a control model. Blockade of endothelin type A
(ETA) receptors in PbA-infected B6 mice prevents development
of ECM, indicating that ET-1 is involved in the disease pathogenesis.
We hypothesize that treatment of mice with PbN infection with
exogenous ET-1 can trigger development of ECM. Mice were infected
with 106 PbN-parasitized red blood cells and treatedwith either ET-1 or
saline. Saline-treated mice did not develop ECM and survived until
12 days post-infection (DPI). ET-1 treated mice died between 4 and
8 DPI and exhibited signs of ECM. ET-1 treatment had no effect on
parasitemia. All infected mice had signiﬁcantly lower rectal tempera-
ture (RT) and body weight (BW ) than uninfected controls over the
course of infection, and reduction in these parameters was signiﬁcantly
greater in mice treated with ET-1 (N20% weight loss). Uninfected mice
treated with ET-1 had a modest reduction in RT but not in BW. Brain
histopathology of PbN-infected mice treated with ET-1 demonstrated
the presence of petechial hemorrhages throughout the parenchyma,
and leukocyte inﬁltration to the endothelia, 6 DPI, which were not
evident in PbN-infected mice treated with saline or in uninfected
control mice. These data indicate that ET-1 triggers the development of
ECM in PbN-infected C57BL/6 mice.
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